Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion

G. E. Linthorst, M. A. de Rie, K. H. Tjiam, J. M. F. G. Aerts, K. P. Dingemans, C. E. M. Hollak

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)

Abstract

Generalized angiokeratoma are associated with three lysosomal storage disorders, one of which is Fabry disease (alpha-galactosidase A deficiency). Treatment for Fabry disease with supplementation of recombinant enzyme is available in the European Union and subsequently physicians' awareness may rise. A patient who was erroneously diagnosed with Fabry disease is presented
Original languageEnglish
Pages (from-to)575-577
JournalBritish Journal of Dermatology
Volume150
Issue number3
DOIs
Publication statusPublished - 2004

Cite this